[Evaluation of the efficacy of nebulized salbutamol in exacerbation of chronic asthma].
The aim of the study was to evaluate the influence of nebulized salbutamol in low doses (0.5 mg, 1 mg, 1.5 mg) on lung function in patients with acute severe asthma. The study was performed in 30 patients--22 female and 8 male. Nebulized salbutamol proved to be an effective bronchodilating drug which enables to control exacerbations in asthmatic patients receiving conventional medical treatment. The evaluation of effect of nebulized salbutamol should take into account both subjective symptoms and (basic) spirometry parameters of airway obstruction such as FEV1 PEF. This therapy can improve the efficacy of asthma management.
Zakładu Alergologii Państwowego Szpitala Klinicznego Nr I w Gdańsku.
G
G
Mincewicz
R
R
Sopel
M
M
Kozłowki
W
W
Kurowski
D000318:Adrenergic beta-Agonists / Q000008:administration & dosage*; D000328:Adult; D000420:Albuterol / Q000008:administration & dosage*; D000553:Ambulatory Care; D001249:Asthma / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D002908:Chronic Disease; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009330:Nebulizers and Vaporizers; D012129:Respiratory Function Tests
D000318:Adrenergic beta-Agonists; D000420:Albuterol
Ocena skuteczności nebulizacji Salbutamolem w zaostrzeniu przewlekłej astmy oskrzelowej.